Regen Biopharma Stock Technical Analysis
| RGBPP Stock | USD 0 0.0007 24.14% |
As of the 15th of February 2026, Regen BioPharma holds the Risk Adjusted Performance of 0.0572, semi deviation of 25.83, and Coefficient Of Variation of 1700.49. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Regen BioPharma, as well as the relationship between them.
Regen BioPharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Regen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RegenRegen |
Regen BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Regen BioPharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Regen BioPharma.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Regen BioPharma on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Regen BioPharma or generate 0.0% return on investment in Regen BioPharma over 90 days. Regen BioPharma is related to or competes with Ayala Pharmaceuticals, and Zelira Therapeutics. Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States More
Regen BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Regen BioPharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Regen BioPharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 34.04 | |||
| Information Ratio | 0.057 | |||
| Maximum Drawdown | 177.88 | |||
| Value At Risk | (48.91) | |||
| Potential Upside | 86.67 |
Regen BioPharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Regen BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Regen BioPharma's standard deviation. In reality, there are many statistical measures that can use Regen BioPharma historical prices to predict the future Regen BioPharma's volatility.| Risk Adjusted Performance | 0.0572 | |||
| Jensen Alpha | 1.63 | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | 0.0635 | |||
| Treynor Ratio | 0.2268 |
Regen BioPharma February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0572 | |||
| Market Risk Adjusted Performance | 0.2368 | |||
| Mean Deviation | 24.67 | |||
| Semi Deviation | 25.83 | |||
| Downside Deviation | 34.04 | |||
| Coefficient Of Variation | 1700.49 | |||
| Standard Deviation | 37.93 | |||
| Variance | 1438.81 | |||
| Information Ratio | 0.057 | |||
| Jensen Alpha | 1.63 | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | 0.0635 | |||
| Treynor Ratio | 0.2268 | |||
| Maximum Drawdown | 177.88 | |||
| Value At Risk | (48.91) | |||
| Potential Upside | 86.67 | |||
| Downside Variance | 1158.38 | |||
| Semi Variance | 667.01 | |||
| Expected Short fall | (40.92) | |||
| Skewness | 1.11 | |||
| Kurtosis | 2.4 |
Regen BioPharma Backtested Returns
Regen BioPharma is out of control given 3 months investment horizon. Regen BioPharma maintains Sharpe Ratio (i.e., Efficiency) of 0.0628, which implies the firm had a 0.0628 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.42% are justified by taking the suggested risk. Use Regen BioPharma Risk Adjusted Performance of 0.0572, coefficient of variation of 1700.49, and Semi Deviation of 25.83 to evaluate company specific risk that cannot be diversified away. Regen BioPharma holds a performance score of 4 on a scale of zero to a hundred. The company holds a Beta of 9.79, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Regen BioPharma will likely underperform. Use Regen BioPharma sortino ratio and the relationship between the downside variance and market facilitation index , to analyze future returns on Regen BioPharma.
Auto-correlation | 0.48 |
Average predictability
Regen BioPharma has average predictability. Overlapping area represents the amount of predictability between Regen BioPharma time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Regen BioPharma price movement. The serial correlation of 0.48 indicates that about 48.0% of current Regen BioPharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Regen BioPharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Regen BioPharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Regen BioPharma across different markets.
About Regen BioPharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Regen BioPharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Regen BioPharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Regen BioPharma price pattern first instead of the macroeconomic environment surrounding Regen BioPharma. By analyzing Regen BioPharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Regen BioPharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Regen BioPharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Regen BioPharma February 15, 2026 Technical Indicators
Most technical analysis of Regen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Regen from various momentum indicators to cycle indicators. When you analyze Regen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0572 | |||
| Market Risk Adjusted Performance | 0.2368 | |||
| Mean Deviation | 24.67 | |||
| Semi Deviation | 25.83 | |||
| Downside Deviation | 34.04 | |||
| Coefficient Of Variation | 1700.49 | |||
| Standard Deviation | 37.93 | |||
| Variance | 1438.81 | |||
| Information Ratio | 0.057 | |||
| Jensen Alpha | 1.63 | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | 0.0635 | |||
| Treynor Ratio | 0.2268 | |||
| Maximum Drawdown | 177.88 | |||
| Value At Risk | (48.91) | |||
| Potential Upside | 86.67 | |||
| Downside Variance | 1158.38 | |||
| Semi Variance | 667.01 | |||
| Expected Short fall | (40.92) | |||
| Skewness | 1.11 | |||
| Kurtosis | 2.4 |
Regen BioPharma February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Regen stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.37 | ||
| Daily Balance Of Power | (0.54) | ||
| Rate Of Daily Change | 0.76 | ||
| Day Median Price | 0.00 | ||
| Day Typical Price | 0.00 | ||
| Price Action Indicator | 0.00 | ||
| Market Facilitation Index | 0 |
Additional Tools for Regen Pink Sheet Analysis
When running Regen BioPharma's price analysis, check to measure Regen BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regen BioPharma is operating at the current time. Most of Regen BioPharma's value examination focuses on studying past and present price action to predict the probability of Regen BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regen BioPharma's price. Additionally, you may evaluate how the addition of Regen BioPharma to your portfolios can decrease your overall portfolio volatility.